Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease

  1. Carrillo-López, N.
  2. Panizo, S.
  3. Alonso-Montes, C.
  4. Román-García, P.
  5. Rodríguez, I.
  6. Martínez-Salgado, C.
  7. Dusso, A.S.
  8. Naves, M.
  9. Cannata-Andía, J.B.
Journal:
Kidney International

ISSN: 1523-1755,  0085-2538

Year of publication: 2016

Volume: 90

Issue: 1

Pages: 77-89

Type: Article

DOI: 10.1016/J.KINT.2016.01.024 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals